Inhibitory effect of mimosine on proliferation of human lung cancer cells is mediated by multiple mechanisms

Cancer Letters

Volumn 145, Issue 1-2, 1999, Pages 1-8

  Chang, Hui Chiu ^a   Lee, Te Hsiu ^a   Chuang, Lea Yea ^a   Yen, Ming Hong ^a   Hung, Wen Chun ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cyclin D1; Cyclin dependent kinase inhibitors; Cyclin dependent kinases; Lung cancer; Mimosine

Indexed keywords

MIMOSINE;

ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL PROLIFERATION; GROWTH DISORDER; GROWTH REGULATION; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL;

CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; G1 PHASE; HUMANS; LUNG NEOPLASMS; MIMOSINE; NEOPLASM PROTEINS; TUMOR CELLS, CULTURED;

EID: 0032888082     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00209-8     Document Type: Article

References (37)

1. Lalande M. A reversible arrest point in the late G1 phase of the mammalian cell cycle. Exp. Cell Res. 186:1990;332-339.
2. Mosca P.J., Dijkwel P.A., Hamlin J.L. The plant amino acid mimosine may inhibit initiation at origins of replication in Chinese hamster cells. Mol. Cell Biol. 12:1992;4375-4383.
3. Wang Y., Zhao J., Clapper J., Martin L.D., Du C., DeVore E.R., Harkins K., Dobbs D.L., Benbow R.M. Mimosine differentially inhibits DNA replication and cell cycle progression in somatic cells compared to embryonic cells of Xenopus laevis. Exp. Cell Res. 217:1995;84-91.
4. Hughes T.A., Cook P.R. Mimosine arrests the cell cycle after cells enter S-phase. Exp. Cell Res. 222:1996;275-280.
5. Dai Y., Gold B., Vishwanatha J.K., Rhode S. Mimosine inhibits viral DNA synthesis through ribonucleotide reductase. Virology. 205:1994;210-216.
6. Gilbert D.M., Neilson A., Miyazawa H., DePamphelis M.L., Burhans W.C. Mimosine arrests DNA synthesis at replication forks by inhibiting deoxynucleotide metabolism. J. Biol. Chem. 270:1995;9597-9606.
7. Lin H., Falchetto R., Mosca P.J., Shabanowitz J., Hunt D.F., Hamlin J.L. Mimosine targets serine methyltransferase. J. Biol. Chem. 271:1996;2548-2556.
8. Nyholm S., Mann G.J., Johansson A.G., Bergeron R.J., Graslund A., Thelander L. Role of ribonucleoide reductase in inhibition of mammalian cell growth by potent iron chelators. J. Biol. Chem. 268:1993;26200-26205.
9. Hanauske-Abl H.M., Park M.H., Hanauske A.R., Popowitcz A.M., Lalande M., Folk J.E. Inhibition of the G1/S transition of the cell cycle by inhibitors of deoxyhypusine hydroxylation. Biochim. Biophys. Acta. 1221:1994;115-124.
10. Lew D.J., Kornbluth S. Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control. Curr. Opin. Cell Biol. 8:1996;795-804.
11. Sherr C.J. Mammalian G1 cyclins. Cell. 73:1993;1059-1065.
12. Hunter T., Pines J. Cyclins and cancer. Cell. 66:1991;1071-1074.
13. Pines J. Cyclins and cyclin-dependent kinase: take your partners. Trends Biochem. Sci. 18:1993;195-197.
14. van den Heuvel S., Harlow E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science. 262:1993;2050-2054.
15. Amon A., Tyers M., Futher B., Nsmyth B. Mechanisms that help the yeast cell cycle clock tick: G2 cyclins transcriptionally activate G2 cyclins and repress G1 cyclins. Cell. 74:1993;993-1007.
16. Guadagno T.M., Newport J.W. Cdk2 kinase is required for entry into mitosis as a positive regulator for Cdc-cyclin B kinase activity. Cell. 84:1996;73-82.
17. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin- dependent kinases. Genes Dev. 9:1995;1149-1163.
18. Serrano M., Hannon G.J., Beach D. new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature. 366:1993;704-707.
19. Hirai H., Roussel M.F., Kato J.Y., Ashmun R.A., Sherr C.J. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell Biol. 15:1995;2672-2681.
20. El-Deiry W., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
21. Polyak K., Lee M.H., Erdjument-Bromage H., Koff A., Roberts J.M., Tempst P., Massague J. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 78:1994;59-66.
22. Sherr C.J. Phase progression: cycling on cue. Cell. 79:1994;551-555.
23. Massaque J., Polyak K. Mammalian antiproliferative signals and their targets. Curr. Opin. Genet. Dev. 5:1995;91-96.
24. Alpan R.S., Pardee A.B. p21WAF1/CIP1/SDI1 is elevated through a p53-indenpendent pathway by mimosine. Cell Growth and Differ. 7:1996;893-901.
25. Hung W.C., Huang J.S., Chuang L.Y. Antisense oligodeoxynucleotides targets against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression. Biochem. Biophys. Res. Commun. 220:1996;719-723.
26. Mitsudomi T., Steinberg S.M., Nau M.M., Carbone D., D'Amico D., Bodner S., Oie H.K., Linnoila R.I., Mulshine J.L., Minna J.D., Gazdar A.F. p53 Gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene. 1992;171-180.
27. Ewen M.E., Sluss H.K., Sherr C.J., Matsushime H., Kato J.Y., Livingston D.M. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell. 73:1993;487-497.
28. Matsushime H., Ewen M.E., Strom D.K., Kato J.Y., Hanks S.K., Roussel M.F., Sherr C.J. Identification and properties of an atypical catalytic subunit (p34/cdk4) for mammalian D type G1 cyclins. Cell. 71:1992;323-334.
29. Motokura T., Bloom T., Kim H.G., Juppner H., Ruderman J., Kronenberg H.M., Arnold A. A novel cyclin encoded by a bcl-linked candidate oncogene. Nature. 350:1991;512-515.
30. Schurring E., Verhoeven E., Mooi W.J., Michalides R.J.A.M. Identification and cloning of two overexpressed genes U21B31/ PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinoma. Oncogene. 7:1992;355-361.
31. Jiang W., Kahn S.M., Tomita N., Zhang Y.L., Lu S.H., Weinstein I.B. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res. 52:1992;2980-2983.
32. Herber B., Truss M., Beato M., Muller R. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene. 9:1994;1295-1304.
33. Navoie J.N., L'Allemain G., Brunt A., Muller R., Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271:1996;20608-20616.
34. Kulp K.S., Green S.L., Vulliet P.R. Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells. Exp. Cell Res. 229:1996;60-68.
35. Yatabe Y., Masuda A., Koshikawa T., Nakamura S., Kuroishi T., Osada H., Tahashi T., Mitsudomi T., Takahashi T. p27KIP1 in human lung cancers: differential changes in small cell and non-small cell carcinomas. Cancer Res. 58:1998;1042-1047.
36. Kondo M., Matsuoka S., Uchida K., Osada H., Nagatake M., Takagi K., Harper J.W., Takahashi T., Elledge S.J., Takahashi T. Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5. Oncogene. 12:1996;1365-1368.
37. Feldman S.T., Schothal A. Negative regulation of histone H1 kinase expression by mimosine, a plant amino acid. Cancer Res. 54:1994;494-498.